Search Results (3)

Background. Modern laser vision correction for presbyopia treatment involves non-linear aspheric corneal ablation with the controlled induction of spherical aberration modulation to extend the depth of focus or corneal multifocality induction methods with or without micro-monovision in the non-dominant eye to provide continuous clear vision across distances. Anisometropia and the new higher-order aberrations pattern may be potential risk factors for postoperative stereopsis and contrast sensitivity (CS) deterioration. Purpose. The objective of this systematic review was to assess articles published until 2023 in which CS and/or stereopsis were reported following LASIK presbyopia treatment. Methods. We searched the PubMed, Scopus and Web of Science databases in accordance with the PRISMA 2020 flow diagram. The inclusion criteria specified original papers evaluating the outcomes of laser presbyopia correction as well as the pre- and postoperative assessment of stereopsis and/or CS. The Quality Assessment Tool was applied to assess the risk of bias. Results. We identified 13 studies, including 856 presbyopes (1712 eyes), with preoperative refractive errors from −11.13 D to +5.75 D, with the follow-up range between 3 and 30 months. Either contrast sensitivity improvement or no change following Presbyond^® Laser Blended Vision and PresbyMAX^® Hybrid was found in the reviewed articles. Some authors reported a significant CS reduction after symmetrical PresbyLASIK, wavefront-guided LASIK and aspheric monovision LASIK. Several studies assessing the effect of Presbyond^® LBV on stereopsis showed conflicting results, with the near stereopsis being reduced, unchanged or increased. A significant decrease in stereopsis was reported after aspheric monovision LASIK. Conclusions. The Presbyond^® Laser Blended Vision is a safe procedure in terms of the preservation of contrast sensitivity for presbyopia treatment. More studies are needed to elucidate the impact of aspheric corneal ablation methods or other methods inducing corneal multifocality with or without micro-monovision on stereopsis and contrast sensitivity. Full article

Background/Objectives: Presbyopia, a common age-related refractive error, affects over a billion people globally and significantly impacts daily life. Methods: This retrospective study analyzed 288 eyes of 144 patients undergoing LBV PRESBYOND^® treatment for myopic presbyopia with astigmatism, aiming to evaluate precision, efficacy, safety, and stability over six months. Results: Key findings include high efficacy, with 99% of distance-eyes achieving uncorrected distance visual acuity (UDVA) of 20/25 or better, and 85% of near-eyes achieving UDVA of 20/32 or better. The results show excellent refractive outcomes, with 99% of long-sighted eyes and 97% of near-sighted eyes having a postoperative spherical equivalent within ±1.00 D. Safety was demonstrated by no loss of two or more Snellen lines after treatment, with 94% of patients maintaining corrected distance visual acuity (CDVA) before and after surgery. Conclusions: Overall, LBV PRESBYOND^® proved effective, safe, and well tolerated for myopic presbyopia correction, offering satisfactory visual outcomes and potential spectacle independence for various distances. This study underscores the importance of individualized treatment based on patient age, highlighting the positive impact of binocular summation on visual function. This study contributes to the growing body of evidence supporting LBV PRESBYOND^® as a viable option for addressing presbyopic myopia, offering insights into its efficacy and safety profile. Further research could explore postoperative stereopsis and long-term outcomes to enhance understanding and refine treatment protocols. Full article

Binocular summation along all defocus range after a micro-monovision procedure has scarcely been studied. The aim of this pilot study was to evaluate the efficacy of SMILE combined with different levels of micro-monovision in presbyopic patients and to assess the binocular summation effect on contrast sensitivity defocus curves (CSDC) at the 6-month follow-up. Efficacy was assessed on the basis of visual acuity (VA) and stereopsis at far, intermediate, and near distances. Patient-reported outcomes (PROs) and binocular CSDC were also evaluated. Six patients completed the study with a programmed median anisometropia of 0.81 Diopter. The median binocular uncorrected VA was better than 0 logMAR at the three evaluated distances, and stereopsis was not impaired in any patient, achieving a median of ≤119 arcsec at any distance. CSDC increased binocularly after surgery, significantly in the range of −2 to −3 D (p < 0.05). No clinically relevant changes were observed in PROs compared with the preoperative period, and all patients achieved spectacle independence at intermediate/near distance and were likely or very likely to undergo the same surgery. In conclusion, micro-monovision with SMILE could be an effective procedure, with results that might be comparable to other laser correction techniques specifically designed for presbyopia correction. Full article